Investigation of the effect of rivastigmine patch on gait disturbance in patients with Alzheimer disease. Clinical study (intervention study).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2018
At a glance
- Drugs Rivastigmine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 30 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 17 Feb 2017 New trial record